Invention Grant
![Design, synthesis, and biological activity of platinum-benz[c]acridine hybrid agents and methods associated therewith](/docs/US/2018-07-17/US10023599B2/abs.jpg.600x600.jpg)
- Patent Title: Design, synthesis, and biological activity of platinum-benz[c]acridine hybrid agents and methods associated therewith
-
Application No.: US15126422Application Date: 2015-03-15
-
Publication No.: US10023599B2Publication Date: 2018-07-17
- Inventor: Ulrich Bierbach , Amanda J Pickard
- Applicant: WAKE FOREST UNIVERSITY
- Applicant Address: US NC Winston-Salem
- Assignee: Wake Forest University
- Current Assignee: Wake Forest University
- Current Assignee Address: US NC Winston-Salem
- Agency: Fox Rothschild LLP
- International Application: PCT/US2015/020635 WO 20150315
- International Announcement: WO2015/142684 WO 20150924
- Main IPC: C07F15/00
- IPC: C07F15/00 ; A61K47/54
![Design, synthesis, and biological activity of platinum-benz[c]acridine hybrid agents and methods associated therewith](/abs-image/US/2018/07/17/US10023599B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to the compounds of formula I, pharmaceutically acceptable salts, and solvates thereof: wherein the various substituents are as defined herein. The compounds, solvates and salts thereof of Formula I are effective as anti-cancer compounds.
Public/Granted literature
Information query
